Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones

Journal of Cataract and Refractive Surgery

Volumn 35, Issue 11, 2009, Pages 1970-1978

  Miyanaga, Masaru ^a   Nejima, Ryohei ^a   Miyai, Takashi ^a   Miyata, Kazunori ^a   Ohashi, Yuichi ^a   Inoue, Yoshitsugu ^a   Toyokawa, Masahiro ^a   Asari, Seishi ^a  

^a Miyata Eye Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PROTEIN PARC; PROTEIN PARE; TOBRAMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CATARACT; CATARACT EXTRACTION; CONJUNCTIVA; CONTROLLED STUDY; ENDOPHTHALMITIS; GENE MUTATION; HUMAN; INFECTION PREVENTION; INFECTIOUS ENDOPHTHALMITIS; JAPAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; CATARACT EXTRACTION; CONJUNCTIVA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; GENES, MDR; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; OFLOXACIN; OPHTHALMIC SOLUTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 72449203844     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2009.05.049     Document Type: Article

References (23)

1. Speaker M.G., Milch F.A., Shah M.K., Eisner W., and Kreiswirth B.N. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98 (1991) 639-649 discussion by J Baum, 650
2. Puliafito C.A., Baker A.S., Haaf J., and Foster C.S. Infectious endophthalmitis; review of 35 cases. Ophthalmology 89 (1982) 921-928 discussion by RK Forster, 928-929
3. Heaven C.J., Mann P.J., and Boase D.L. Endophthalmitis following extracapsular cataract surgery: a review of 32 cases. Br J Ophthalmol 76 (1992) 419-423. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=504303&blobtyp e=pdf Accessed July 17, 2009.
4. Han D.P., Wisniewski S.R., Wilson L.A., Barza M., Vine A.K., Doft B.H., and Kelsey S.F. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study; the Endophthalmitis Vitrectomy Study Group. Am J Ophthalmol 122 (1996) 1-17 correction, 920
5. Bannerman T.L., Rhoden D.L., McAllister S.K., Miller J.M., and Wilson L.A. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study; a comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis; the Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 115 (1997) 357-361
6. Sandvig K.U., and Dannevig L. Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg 29 (2003) 1273-1280
7. Suzuki T., Kawamura Y., Uno T., Ohashi Y., and Ezaki T. Prevalence of Staphylococcus epidermidis strains with biofilm-forming ability in isolates from conjunctiva and facial skin. Am J Ophthalmol 140 (2005) 844-850
8. Inoue Y., Usui M., Ohashi Y., Shiota H., and Yamazaki T. Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study; for the Preoperative Disinfection Study Group. Jpn J Ophthalmol 52 (2008) 151-161
9. Goldstein M.H., Kowalski R.P., and Gordon Y.J. Emerging fluoroquinolone resistance in bacterial keratitis; a 5-year review. Ophthalmology 106 (1999) 1313-1318
10. Kurokawa N., Hayashi K., Konishi M., Yamada M., Noda T., and Mashima Y. Increasing ofloxacin resistance of bacterial flora from conjunctival sac of preoperative ophthalmic patients in Japan. Jpn J Ophthalmol 46 (2002) 586-589
11. Chalita M.R., Höfling-Lima A.L., Paranhos Jr. A., Schor P., and Belfort Jr. R. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol 137 (2004) 43-51
12. Hori Y., Maeda N., Sakamoto M., Inoue T., and Tano Y. Fluoroquinolone-resistant bacteria and methicillin-resistant Staphylococci from normal preoperative conjunctiva. J Cataract Refract Surg 34 (2008) 711-712
13. Yamada M., Yoshida J., Hatou S., Yoshida T., and Minagawa Y. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Br J Ophthalmol 92 (2008) 848-851
14. Iihara H., Suzuki T., Kawamura Y., Ohkusu K., Inoue Y., Zhang W., Shah M.M., Katagiri Y., Ohashi Y., and Ezaki T. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. Diagn Microbiol Infect Dis 56 (2006) 297-303
15. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard-six edition M7-A7 (2006), CLSI, Wayne, PA
16. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, M100-S18 (2008), CLSI, Wayne, PA
17. Sato M., Oshika T., and Kinoshita S. [2005 Survey Japanese Society of Cataract and Refractive Surgery Members]. [Japanese] IOL&RS 20 (2006) 269-289
18. Okumura N., Hashida M., Kojima K., Urabe K., and Machida T. [Effect of long-term topical levofloxacin on conjunctival bacterial flora]. [Japanese] Atarashii Ganka 21 (2004) 1531-1534
19. Takei M., Fukuda H., Kishii R., and Hosaka M. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob Agents Chemother 45 (2001) 3544-3547. http://aac.asm.org/cgi/reprint/45/12/3544 Accessed July 17, 2009
20. Fukuda H., Hori S., and Hiramatsu K. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Antimicrob Agents Chemother 42 (1998) 1917-1922. http://aac.asm.org/cgi/reprint/42/8/1917 Accessed July 17, 2009
21. Li Z., Deguchi T., Yasuda M., Kawamura T., Kanematsu E., Nishino Y., Ishihara S., and Kawada Y. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother 42 (1998) 3293-3295. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=106039&blobtyp e=pdf Accessed July 17, 2009
22. Dubin D.T., Fitzgibbon J.E., Nahvi M.D., and John J.F. Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob Agents Chemother 43 (1999) 1631-1637. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=89335&blobtype =pdf Accessed July 17, 2009
23. 87. Antimicrob Agents Chemother 45 (2001) 1994-2000. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=90591&blobtype =pdf Accessed July 17, 2009